StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3024% below fair value
$4.33−0.06 (-1.37%)

Close on Nov 13, 2026Market cap $122.21MP/E –Yield –

Journey Medical total assets

Total assets on the balance sheet at the end of each period.

Journey Medical's total assets was $103.85M at Sep 30, 2026. For fiscal 2025 it was $94.59M, up 17.9% from the year before. The highest annual figure on record is $105.16M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$94.59M+17.9%
FY2024Dec 31, 2024$80.24M+4.4%
FY2023Dec 31, 2023$76.85M-26.9%
FY2022Dec 31, 2022$105.16M+8.1%
FY2021Dec 31, 2021$97.28M+87.4%
FY2020Dec 31, 2020$51.91M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$103.85M+21.9%
Q2 FY2026Jun 30, 2026$98.36M+21.2%
Q1 FY2026Mar 31, 2026$91.53M+7.7%
Q4 FY2025Dec 31, 2025$94.59M+17.9%
Q3 FY2025Sep 30, 2025$85.19M+33.0%
Q2 FY2025Jun 30, 2025$81.16M+24.5%
Q1 FY2025Mar 31, 2025$84.96M+27.6%
Q4 FY2024Dec 31, 2024$80.24M+4.4%
Q3 FY2024Sep 30, 2024$64.04M-2.8%
Q2 FY2024Jun 30, 2024$65.19M-6.5%
Q1 FY2024Mar 31, 2024$66.57M-36.7%
Q4 FY2023Dec 31, 2023$76.85M-28.9%
Q3 FY2023Sep 30, 2023$65.92M-41.9%
Q2 FY2023Jun 30, 2023$69.75M-42.3%
Q4 FY2022Dec 31, 2022$105.16M+8.1%
Q3 FY2022Sep 30, 2022$108.15M+21.4%
Q2 FY2022Jun 30, 2022$113.50M+118.7%
Q1 FY2022Mar 31, 2022$120.90M–
Q4 FY2021Dec 31, 2021$97.28M–
Q3 FY2021Sep 30, 2021$89.06M–
Q4 FY2020Dec 31, 2020$51.91M–

More Journey Medical figures

See a number that looks wrong?